EGFR and breast cancer: FEN1-mediated DNMT3a up-regulation, released the suppression of its targeting MET and EGFR, and promoted breast cancer cell proliferation by activating PI3K/AKT and MAPK/ERK pathways in MCF-7cells (Zeng et al., 2019).